The global CNS therapeutics market size was valued at USD 150.58 billion in 2025 and is projected to grow from USD 165.46 billion in 2026 to USD 351.59 billion by 2034, registering a CAGR of 9.88% during the forecast period (2026–2034). The CNS therapeutics market is experiencing substantial growth due to the increasing prevalence of neurological disorders, psychiatric conditions, and neurodegenerative diseases worldwide. https://straitsresearch.com/report/cns-therapeutics-market